CytomX Therapeutics, Inc. (CTMX) CX-2051 Phase 1 Interim Clinical Data Call (Transcript)
…
4,110$
-1,91%
Echtzeit-Aktienkurs CytomX Therapeutics
Bid:
Ask:
Nachrichten zur CytomX Therapeutics Aktie
CytomX Therapeutics to Report First Quarter 2025 Financial Results on May 12, 2025
SOUTH SAN FRANCISCO, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in…
CytomX Therapeutics, Inc. (CTMX) Q3 2024 Earnings Call Transcript
…
CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in…
CytomX Therapeutics, Inc. (CTMX) Q1 2024 Earnings Call Transcript
…
CytomX Therapeutics, Inc. (CTMX) Q4 2023 Earnings Call Transcript
…